HMGB1 and serum lipopolysaccharide activity: Circulating HMGB1 is increased during endotoxemia/sepsis and antibody-mediated disruption of HMGB1-LPS binding confers resistance to sepsis (Yang et al., 2004; Sundén-Cullberg et al., 2005; Youn et al., 2008).